Nektar Therapeutics NKTR Q1 2025 earnings
Reported May 8, 2025 · After market close
Revenue$10.5MMiss by $4.9M
EPS-$3.30Miss by $0.60
Revenue estimate$15.4M
EPS estimate-$2.70
Next report
Aug 6, 2026 (In 1 week)Revenue estimate$10.4M
EPS estimate-$1.94
Financials
Q1 2025Valuation & ratios
Segments
Versus estimates
Revenue
Diluted EPS
Ask the moment Nektar Therapeutics reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Nektar Therapeutics report Q1 2025 earnings?
- Nektar Therapeutics (NKTR) reported Q1 2025 earnings on May 8, 2025 after market close.
- What were Nektar Therapeutics's Q1 2025 revenue and EPS?
- Nektar Therapeutics reported revenue of $10.5M and eps of $-3.30 for Q1 2025.
- Did Nektar Therapeutics beat estimates in Q1 2025?
- Revenue missed the consensus estimate of $15.4M by $4.9M. EPS missed the consensus estimate of $-2.70 by $0.60.
- How did Nektar Therapeutics's Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 51.7% from $21.6M a year earlier and eps declined 1733.3% from $-0.18.
- Where can I find Nektar Therapeutics's Q1 2025 SEC filings?
- You can read the 10-Q periodic report (0000950170-25-067279) directly on SEC EDGAR. The filing index links above go to sec.gov.